Researchers Identify Best Drug Therapy for Rare, Aggressive Pancreatic Cancer

Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care. John A. Copland, III, Ph.D., discusses a study involving researchers on Mayo Clinic’s campuses in Jacksonville, Florida, and Rochester, Minnesota, who found that the chemotherapy drug oxaliplatin is effective in stopping the growth of this cancer.

 

 

Related Videos